Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadratus lumborum block with or without hyaluronidase for analgesia in laparoscopic inguinal hernia repair
PACTR202603652164523Not yet recruiting
- Sponsor
- Mansoura University Hospitals
- Start
- Apr 2026
- Modality
- Small Molecules, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of bupivacaine and hyaluronidase in inguinal hernia (2 arms), sponsored by Mansoura University Hospitals. Primary endpoint: VAS score 12 hours post operative. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
bupivacainehyaluronidase
03
Conditions
inguinal hernia
Beyond the preview
Go deeper on PACTR202603652164523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202603652164523.